Page 46 - Sanket Koul

'Two-thirds of greenfield units under PLI for bulk drugs completed'

Union Minister of Chemical and Fertilisers Mansukh Mandaviya on Saturday inaugurated 40 greenfield facilities to manufacture bulk drugs and medical devices under the PLI scheme

Vitamin B12 supplements market steadily growing in India, shows data

The market for Vitamin B12 supplements is expanding, according to data from clinical research agency IQVIA.

CRSA proposes inclusion of robotic surgery in medical curriculum via NMC

More surgeons need to be trained to make robotic surgery accessible, body says

Major hospital chains report increase in average revenue per occupied bed

The increase in ARPOB comes despite significant bed additions by hospitals in the past two financial years

Roche Pharma launches new drug for multiple sclerosis treatment in India

With the launch of the new drug, the global pharma company hopes to expand its neurology portfolio and cater to the untapped need of patients facing the disease in India

Bristol Myers Squibb opens innovation hub worth $100 million in Hyderabad

"The state-of-the-art site will expand the company's global drug development and IT & digital capabilities and is expected to be home to over 1,500 employees," the company said in its release

Sprawling bungalow in Lutyens' Delhi on the block for Rs 325 crore

Given their scarcity, JLL projects properties in Lutyens Bungalow Zone will come up for sale only once a year over the next 4 to 5 years

27.9 mn Ayushman Cards created under Viksit Bharat Yatra: Health ministry

The VBSY was launched by Prime Minister Narendra Modi on November 15 last year from Jharkhand's Khunti

NBCC gets nod from Greater Noida Authority to build five Amrapali projects

The approval is for the development of unused and purchasable floor area ratio (FAR) "in furtherance of existing projects of Amrapali valuing approximately Rs 10,000 crore," the company said

AyushMin gets rap for underuse of funds despite rising allocation

Expenditure for scheme stands at 74% and 85% of RE in FY24 and FY23

PM Narendra Modi to inaugurate 7 Aiims worth Rs 10,000 crore in 10 days

"PM Modi will lay the foundation stone of Aiims Rewari on 16 February, while six Aiims will be inaugurated in two tranches," Mansukh Mandaviya said

Agilus Diagnostics to withdraw DRHP filed with market regulator Sebi

The company added that making the necessary application to Sebi for withdrawal of the said DRHP immediately and may re-file with Sebi again for a proposed IPO in future

Parliamentary standing committee pitches for ramping up medical seats

Panel report recommends faculty development programs, institute for training medical teachers

Aurobindo Pharma Q3 results: Profit up 91.43%, revenue rises 14.7%

The company's revenue from formulations increased by 17.2 per cent Y-o-Y to Rs 6,291 crore. Sequentially, it was up by 5.4 per cent from Rs 5,968 crore in Q2 FY24

Yatharth Hospital to acquire Faridabad-based Fidelis hospital for Rs 116 cr

Yatharth Hospital added that the bed capacity will be expanded to 200 to 220 beds post acquisition

Govt to launch central databases for citizens to track doctors' credentials

Patients to benefit from the move especially in rural areas

Max Healthcare to acquire Nagpur-based Alexis Hospital for Rs 412 rore

Max Healthcare added that the bed capacity can be expanded to 340 beds in view of the availability of the floor area ratio for the given land and the strength of the existing structure

Max Healthcare acquires Nagpur-based Alexis Hospital for Rs 412 cr

Acquisition strengthens presence in Maharashtra and part of strategy to expand in Tier-II cities, says Max Healthcare

Medanta Q3 results: Profit up 53% at Rs 123.54 cr, revenue up 19.9%

Consolidated net profit fell by 1.29 per cent from Rs 125.16 crore, whereas revenue fell by 1.34 per cent from Rs 843.93 crore in Q2 FY24

Mankind Pharma promoters to divest 1.62% stake to comply with Sebi norms

The current aggregate promoter and promoter group shareholding as on February 7 is 76.50 per cent of the total paid-up equity share capital of the company